A Garretson biotechnology firm was issued a patent recently for work it is doing to develop a vaccine that can be used for a number of applications including to help stem obesity and fight Type II diabetes.
Garretson firm obtains patent to foster vaccine
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment